20 February 2025
This lecture explores the role of anti-amyloid therapy in the management of Alzheimer's Disease (AD), focusing on its clinical application, challenges, and impact. The session begins with a case scenario and delves into managing complications such as Amyloid-Related Imaging Abnormalities (ARIA), which can present as asymptomatic microhemorrhages or vasogenic edema, highlighting the importance of early detection and dose adjustments. Evidence from clinical trials demonstrating reduced amyloid plaque burden and slower cognitive decline with agents like lecanemab is reviewed.
The lecture concludes with the clinical impact of these treatments, emphasizing the need for patient selection, and long-term safety monitoring to optimize outcomes.
After the lecture, the participants will be able to gain an understanding on:
Click here for more lecture details.
To register (internet access is required), scan the QR code or click on the web link. Registration closes on 31 January 2025, Friday.
https://form.gov.sg/675f069b4c1b13bd1441a8c6
Upon registration, participants agreed to PGAHI Terms & Conditions. Kindly note that PGAHI reserves the right of final decision on lecture registration.
Lecture Details
Date:
20 February 2025, Thursday
Timing:
6.30 pm - 7.30 pm
Duration:
60 minutes
Fees:
Complimentary
Platform:
Zoom Cloud Meetings
Registration Closing Date:
31 January 2025, Friday
Target Audience:
Pharmacists
(Zoom Capacity: 500
This lecture will be conducted via Zoom Cloud Meetings app. For ease of accessing the lecture, please download/update Zoom Cloud Meetings app. Details of the lecture meeting link will be sent to the successful registrants nearer the lecture date.)
